Congenital disorders of glycosylation and infantile epilepsy

Epilepsy Behav. 2023 May:142:109214. doi: 10.1016/j.yebeh.2023.109214. Epub 2023 Apr 21.


Congenital disorders of glycosylation (CDG) are a group of rare inherited metabolic disorders caused by defects in various defects of protein or lipid glycosylation pathways. The symptoms and signs of CDG usually develop in infancy. Epilepsy is commonly observed in CDG individuals and is often a presenting symptom. These epilepsies can present across the lifespan, share features of refractoriness to antiseizure medications, and are often associated with comorbid developmental delay, psychomotor regression, intellectual disability, and behavioral problems. In this review, we discuss CDG and infantile epilepsy, focusing on an overview of clinical manifestations and electroencephalographic features. Finally, we propose a tiered approach that will permit a clinician to systematically investigate and identify CDG earlier, and furthermore, to provide genetic counseling for the family.

Keywords: Congenital disorders of glycosylation; Epilepsy; Infants.

Publication types

  • Review

MeSH terms

  • Congenital Disorders of Glycosylation* / complications
  • Congenital Disorders of Glycosylation* / diagnosis
  • Congenital Disorders of Glycosylation* / genetics
  • Electroencephalography / adverse effects
  • Epilepsy* / diagnosis
  • Glycosylation
  • Humans
  • Intellectual Disability* / complications